Clinical Outcomes and New Treatments in Pediatric Brain Tumors
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Neuro-Oncology".
Deadline for manuscript submissions: 15 April 2025 | Viewed by 30
Special Issue Editors
Interests: pediatric neuro-oncologie; low-grade gliomas; targeted therapy; clinical trials
Special Issue Information
Dear Colleagues,
Brain tumors are currently the leading cause of cancer deaths in pediatrics. The heterogeneity and aggressiveness of pediatric brain tumors have historically made them difficult to treat. The purpose of this Special Issue is to discuss the latest clinical outcomes and therapeutic treatments for pediatric brain tumors. Given the fact that new treatment approaches now overlap multiple tumor types, we will cover topics by reviewing various fields, from targeted therapies to new surgical techniques.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Medical and patient perspectives;
- Observational approaches;
- Targeted therapies;
- Other small molecules;
- Chemotherapy;
- Immunotherapy;
- Radiation therapy approaches;
- Surgery;
- New devices;
- Approaches to reduce toxicity.
We look forward to receiving your contributions.
Dr. Sébastien Perreault
Dr. Craig Erker
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatric neuro-oncology
- central nervous system tumors
- treatment approaches
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
